Ex-Alcon executive appointed to Visioneering Technologies board

Company News

Medical device company Visioneering Technologies (ASX:VTI) has announced the appointment of Mr Tom Dooley to its Board of Directors as a non-executive director.

The company is engaged in the design, manufacture, sale and distribution of its NaturalVueTM Multifocal 1 Day (NaturalVue MF) contact lenses.

Mr Dooley most recently served as president of Alcon Japan, where he was responsible for 1,300 employees and over US$1 billion in annual sales of the company’s products, including medical devices, pharmaceuticals, and contact lens care.

Before moving to Japan, he served as Alcon’s country manager in Australia and New Zealand. His appointment brings significant executive-level experience and knowledge to the VTI board.

Dr Stephen Snowdy, CEO and executive director at Visioneering Technologies, said: “On behalf of Visioneering’s executive leadership and Board of Directors, we warmly welcome Mr Dooley to the Company. Mr Dooley will contribute to VTI’s management a lifetime of experience and strategic guidance during our rapid sales force expansion, growth of the organisation, and expansion into international markets. We are excited to add another independent board member who understands our industry well, and we look forward to working with him on new endeavours.”

Mr Dooley holds a Bachelor of Science in Agricultural Economics from Purdue University.